Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (
Email Bruce Kamich

Recent Articles By The Author

Chillin' Yeti Is Heating Up to Break Out to New Highs

Time to camp out with this outdoor lifestyle stock?

Callaway Golf Looks Ready to Swing Into Action

It's hard to say this will be a hole in one, but ELY appears like it will work higher and a breakout over the highs of 2018 will be possible.

Nucor Looks Good With or Without an Infrastructure Bill

The charts of the steel company are positive right now.

Should U.S. Concrete Be in Your Infrastructure Mix?

Let's check out the charts of USCR.

Martin Marietta Materials Could Trade Higher as the Year Progresses

Let's review the charts and indicators.

An Upside Move for Canopy Growth Could Be Coming Soon

Here's how investors can trade the cannabis stock.

McDonald's Could Drive Through Resistance So Go Long Here

The technical signs of the fast food giant indicate a minor rally could propel its shares much higher.

Qualcomm Is Poised for an Important Upside Breakout

Here's how traders can play the semiconductor stock.

American Tower Is Still Signaling Upside

Analysis and trading strategy for the communications real estate REIT.

Eli Lilly Shoots Up Following Drug Study

Potential for a new blockbuster breast cancer treatment is eyed as possible game changer, so let's see the charts and indicators for a new target.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight